Julia F. Post

Julia Post is an associate in the firm’s Washington, DC office, where she is a member of the Litigation and Food and Drug practice groups.  Her practice consists primarily of representing clients in Hatch-Waxman patent litigation and providing advice to clients on a variety of federal and state regulatory matters relating to drugs and devices.

Representative Matters

• Representation of a major pharmaceutical company in Hatch-Waxman litigation against generic drug manufacturers concerning oral formulations used to treat ulcerative colitis.
• Representation of a pharmaceutical company in an ANDA case concerning a topical formulation used to treat actinic keratosis.
• Advised major pharmaceutical company regarding state laws governing the marketing of medical devices directly to consumers.
• Advised trade association regarding proposed legislative changes to the FDCA.
• Advised pharmaceutical company regarding state laws and regulations governing generic drug substitution.

Previous Experience

• Booz Allen Hamilton, Consultant (2006-2007)
• The Johns Hopkins Berman Institute of Bioethics, Research Assistant (2005-2006)

Pro Bono

• Serving as guardian ad litem in a child custody dispute in D.C. Superior Court.

Publications and Speeches

• "Summary of FDA Advertising and Promotion Enforcement Activities - February 2013," Covington E-Alert (3/28/2013), Co-Author
• "2012 End-of-Year Summary of FDA Promotional Enforcement Activity," Covington E-Alert (3/18/2013), Co-Author
• "Summary of FDA Advertising and Promotion Enforcement Activities - January 2013," Covington E-Alert (2/27/2013), Co-Author